Bristol Myers Squibb sponsors a study A Phase 1/2, Open-label Study of Nivolumab Monotherapy or Nivolumab Combined With Ipilimumab in Subjects With Advanced or Metastatic Solid Tumors
Can you help Patricia?
She is a 60 year old cancer patient currently at MDA. Here is a little bit about her:
Continue reading "Bristol-Myers Squibb NCT01928394 Can you Help Patricia? " »
Recent Comments